Oaktree Acquisition III Life Sciences Corp

Aktienanalyse zu Oaktree Acquisition III Life Sciences Corp (OACC)

$10.720

0.000 (0.00%)Zum Schluss

Loading chart…
Hoch
10.720
Eröffnung
10.720
Volumengewichteter Durchschnittskurs
10.72
Volumen
18.00
Marktkap.
—
Tief
10.720
Umsatz
192.96
EV/EBITDA, TTM
0.00

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues.

KI-Analyse of Oaktree Acquisition III Life Sciences Corp (OACC)

Halten

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Oaktree Acquisition III Life Sciences Corp (OACC) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
0.06
Aktuelles P/S
0.00
Überbewertet
0.84
Unterbewertet
-0.72

Alphio-AI-Kursszenarien für OACC

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%OACC

$12.28

Szenariopreis

B

Basis

Basis · 50%OACC

$11.50

Szenariopreis

B

Bärisch

Bärisch · 25%OACC

$10.82

Szenariopreis

Whales, die OACC halten

E

Empyrean Capital Partners, LP

+ HältOACC

-3.81%

3-Monats-Rendite

OACC FAQ – beantwortet von Alphio AI

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln